We also noted a non-significant trend for an increase in SGPL1, the other S1P degradation enzyme, in healthy smokers and both and current-and ex-smoker COPD subjects as well as a positive correlation with SGPP2, suggesting a link between these two enzymes in alveolar macrophages in COPD. Here, SGPP2 is linked to chronic obstructive pulmonary disease.